Novartis calls on Covance to help with Big Data
Covance’s collection of drug development data is set to get bigger though a collaboration with Swiss drugmaker Novartis.
Archives for October 15, 2014
AbbVie leaves $50bn Shire deal for dead following US tax rule changes
AbbVie’s proposed £31bn ($50bn) takeover of Shire is very likely “dead” after the US biopharma's board changed its recommendation and advised shareholders not to back the bid.
News from cphi
Big Pharmas and API suppliers eyeing Brazilian Government deals says EMS
Government contracts guaranteeing market share in Brazil are starting to attract innovators like Roche, Novartis and Sanofi and may see API suppliers get long-term work according to a spokesman for Sao Bernardo do Campo-based drugmaker, EMS.
MedImmune teams with UK academics on neurodegenerative disease research
MedImmune’s neurodegenerative disease partnership with the University of Cambridge is about working with “great scientists with great brains” according to a spokeswoman for parent company, AstraZeneca.
news from cphi
CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ
Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.